|
Jul 25
|
Press Release: Online availability of Sanofi’s half-year financial report for 2024
|
|
Jul 25
|
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
|
|
Jul 25
|
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
|
|
Jul 25
|
Sanofi’s immunology bet starts to pay off
|
|
Jul 25
|
Sanofi: Q2 Earnings Snapshot
|
|
Jul 25
|
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
|
|
Jul 25
|
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
|
|
Jul 24
|
The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
|
|
Jul 23
|
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
|
|
Jul 23
|
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
|
|
Jul 23
|
Novavax's (NVAX) Shares Surge 211% YTD: Time to Buy the Stock?
|
|
Jun 14
|
Is It Too Late to Buy Novavax Stock?
|
|
Jun 13
|
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
|
|
Jun 13
|
Exploring Three Top Dividend Stocks On Euronext Paris
|
|
Jun 12
|
Sanofi: Information concerning the total number of voting rights and shares – May 2024
|
|
Jun 12
|
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
|
|
Jun 11
|
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
|
|
Jun 11
|
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
|
|
Jun 10
|
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
|
|
Jun 10
|
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
|